Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

LBM415

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Peptide deformylase (PDF) inhibitors represent a potential new class of antibiotics targeting a large number of bacterial species… Expand
2009
2009
ABSTRACT LBM415 is an antibacterial agent belonging to the peptide deformylase inhibitor class of compounds. It has previously… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
2007
2007
ABSTRACT Previous genetic analysis of Haemophilus influenzae revealed two mechanisms associated with decreased susceptibility to… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
2006
2006
OBJECTIVES To evaluate the spectrum of activity and potency of LBM415, the first of the peptide deformylase inhibitor (PDFI… Expand
  • table 1
  • table 2
  • table 2
  • table 2
  • table 3
Highly Cited
2005
Highly Cited
2005
ABSTRACT LBM415 (NVP PDF-713) is the first member of the peptide deformylase (PDF) inhibitor class being developed for clinical… Expand
  • figure 1
  • table 1
  • table 2
  • table 4
  • table 3
2005
2005
ABSTRACT Haemophilus influenzae isolates vary widely in their susceptibilities to the peptide deformylase inhibitor LBM415 (MIC… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
2005
2005
ABSTRACT Mycoplasma pneumoniae is a major cause of community-acquired pneumonia. We evaluated the efficacy of LBM415, a novel… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2005
2005
ABSTRACT LBM415 activity against extracellular and intracellular Legionella pneumophila was studied. The LBM415 MIC50 for 20… Expand
  • figure 1
  • table 1
2004
2004
ABSTRACT The MICs of LBM415, a new peptide diformylase inhibitor, were ≤0.06 to 4.0 μg/ml for 258 isolates of Staphylococcus… Expand
  • table 1
  • table 2
  • table 3
  • table 4
2004
2004
ABSTRACT The MICs of LBM415, a new peptide diformylase inhibitor, were evaluated and ranged from 0.03 to 4.0 μg/ml for 300… Expand